Akero Therapeutics Inc
AKRO48.620USD
+0.250+0.52%
終値 08/04, 16:00（ET）15分遅れの株価
48.620USD+48.620時間外取引 (ET)
3.87B時価総額
損失額直近12ヶ月PER
四半期
四半期+年間
四半期
年間
YOY
空白行を非表示にする
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
営業費用
34.91%80.88M
26.11%78.03M
75.27%81.70M
84.52%65.74M
108.51%59.95M
143.40%61.87M
29.16%46.62M
29.12%35.63M
10.37%28.75M
-21.64%25.42M
48.20%36.09M
-4.74%27.59M
72.20%26.05M
8.92%32.44M
13.07%24.35M
76.04%28.97M
22.21%15.13M
83.61%29.78M
32.06%21.54M
116.24%16.45M
124.58%12.38M
446.53%16.22M
844.35%16.31M
-12.16%7.61M
1209.26%5.51M
444.59%2.97M
--1.73M
--8.66M
--421.00K
--545.00K
研究 & 開発費
37.35%69.57M
29.78%69.29M
86.96%72.23M
97.68%55.32M
132.48%50.65M
191.44%53.39M
54.00%38.63M
31.00%27.98M
6.21%21.79M
-33.89%18.32M
28.85%25.09M
-10.90%21.36M
93.49%20.51M
7.79%27.71M
12.03%19.47M
83.91%23.98M
20.60%10.60M
95.68%25.71M
25.16%17.38M
118.74%13.04M
116.37%8.79M
562.20%13.14M
1009.03%13.88M
-29.22%5.96M
1697.79%4.06M
446.56%1.98M
--1.25M
--8.42M
--226.00K
--363.00K
減価償却費、減耗費および償却費
-100.00%0.00
650.00%15.00K
-80.00%1.00K
-90.91%1.00K
-90.91%1.00K
-80.00%2.00K
-54.55%5.00K
0.00%11.00K
0.00%11.00K
-9.09%10.00K
22.22%11.00K
10.00%11.00K
0.00%11.00K
0.00%11.00K
50.00%9.00K
--10.00K
--11.00K
--11.00K
--6.00K
----
----
----
----
----
----
----
----
----
----
----
営業利益
-34.91%-80.88M
-26.11%-78.03M
-75.27%-81.70M
-84.52%-65.74M
-108.51%-59.95M
-143.40%-61.87M
-29.16%-46.62M
-29.12%-35.63M
-10.37%-28.75M
21.64%-25.42M
-48.20%-36.09M
4.74%-27.59M
-72.20%-26.05M
-8.92%-32.44M
-13.07%-24.35M
-76.04%-28.97M
-22.21%-15.13M
-83.61%-29.78M
-32.06%-21.54M
-116.24%-16.45M
-124.58%-12.38M
-446.53%-16.22M
-844.35%-16.31M
12.16%-7.61M
-1209.26%-5.51M
-444.59%-2.97M
---1.73M
---8.66M
---421.00K
---545.00K
営業外受取（支払）利息純額
営業外受取利息
48.81%11.31M
21.32%9.20M
30.60%10.24M
103.31%10.98M
124.95%7.60M
--7.58M
798.51%7.84M
2114.34%5.40M
15259.09%3.38M
----
3695.65%873.00K
639.39%244.00K
-42.11%22.00K
-79.17%15.00K
-82.96%23.00K
-86.64%33.00K
-92.29%38.00K
--72.00K
--135.00K
--247.00K
--493.00K
----
----
----
----
----
----
----
----
----
営業外支払利息
16.45%1.15M
33.78%1.20M
40.32%1.25M
43.64%1.23M
116.85%991.00K
-40.24%897.00K
174.07%888.00K
1516.98%857.00K
--457.00K
--1.50M
--324.00K
--53.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
その他営業外収益（費用）
----
----
----
----
----
----
----
----
----
--3.86M
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
101.04%610.00K
108.01%755.00K
3563.64%381.00K
--150.00K
---58.50M
---9.42M
---11.00K
--0.00
--0.00
税引前利益
-32.58%-70.72M
-26.89%-70.02M
-83.33%-72.70M
-80.12%-55.99M
-106.51%-53.34M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.40M
-72.49%-26.03M
-9.13%-32.42M
-13.68%-24.33M
-78.52%-28.93M
-26.96%-15.09M
-90.32%-29.71M
-37.60%-21.40M
-124.23%-16.21M
-121.67%-11.89M
74.60%-15.61M
-39.52%-15.55M
16.66%-7.23M
-1173.63%-5.36M
-11179.27%-61.47M
---11.15M
---8.67M
---421.00K
---545.00K
税引後利益
-32.58%-70.72M
-26.89%-70.02M
-83.33%-72.70M
-80.12%-55.99M
-106.51%-53.34M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.40M
-72.49%-26.03M
-9.13%-32.42M
-13.68%-24.33M
-78.52%-28.93M
-26.96%-15.09M
-90.32%-29.71M
-37.60%-21.40M
-124.23%-16.21M
-121.67%-11.89M
74.60%-15.61M
-39.52%-15.55M
16.66%-7.23M
-1173.63%-5.36M
-11179.27%-61.47M
---11.15M
---8.67M
---421.00K
---545.00K
継続事業による純利益
-32.58%-70.72M
-26.89%-70.02M
-83.33%-72.70M
-80.12%-55.99M
-106.51%-53.34M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.40M
-72.49%-26.03M
-9.13%-32.42M
-13.68%-24.33M
-78.52%-28.93M
-26.96%-15.09M
-90.32%-29.71M
-37.60%-21.40M
-124.23%-16.21M
-121.67%-11.89M
74.60%-15.61M
-39.52%-15.55M
16.66%-7.23M
-1173.63%-5.36M
-11179.27%-61.47M
---11.15M
---8.67M
---421.00K
---545.00K
親会社株主に帰属する当期純利益
-32.58%-70.72M
-26.89%-70.02M
-83.33%-72.70M
-80.12%-55.99M
-106.51%-53.34M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.40M
-72.49%-26.03M
-9.13%-32.42M
-13.68%-24.33M
-78.52%-28.93M
-26.96%-15.09M
-90.32%-29.71M
-37.60%-21.40M
-124.23%-16.21M
-121.67%-11.89M
74.69%-15.61M
-36.45%-15.55M
17.33%-7.23M
-1173.63%-5.36M
-10317.40%-61.67M
---11.40M
---8.74M
---421.00K
---592.00K
優先株配当金
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
323.40%199.00K
--321.00K
----
----
--47.00K
普通株主に帰属する純利益
-32.58%-70.72M
-26.89%-70.02M
-83.33%-72.70M
-80.12%-55.99M
-106.51%-53.34M
-139.33%-55.19M
-11.58%-39.66M
-13.43%-31.08M
0.76%-25.83M
28.88%-23.06M
-46.08%-35.54M
5.29%-27.40M
-72.49%-26.03M
-9.13%-32.42M
-13.68%-24.33M
-78.52%-28.93M
-26.96%-15.09M
-90.32%-29.71M
-37.60%-21.40M
-124.23%-16.21M
-121.67%-11.89M
74.69%-15.61M
-36.45%-15.55M
17.33%-7.23M
-1173.63%-5.36M
-10317.40%-61.67M
---11.40M
---8.74M
---421.00K
---592.00K
基本的1株当たり利益
0.03%-0.90
-0.20%-0.99
-46.82%-1.05
-35.08%-0.81
-63.46%-0.90
-101.09%-0.99
22.43%-0.71
22.62%-0.60
26.00%-0.55
47.04%-0.49
-31.72%-0.92
6.81%-0.77
-71.20%-0.74
-8.57%-0.93
-10.87%-0.70
-46.67%-0.83
-4.14%-0.43
-56.80%-0.86
-15.57%-0.63
-123.85%-0.57
-110.36%-0.42
76.06%-0.55
-29.22%-0.54
21.70%-0.25
-1173.35%-0.20
-10317.09%-2.28
---0.42
---0.32
---0.02
---0.02
希薄化後1株当たり利益
0.03%-0.90
-0.20%-0.99
-46.82%-1.05
-35.08%-0.81
-63.46%-0.90
-101.09%-0.99
22.43%-0.71
22.62%-0.60
26.00%-0.55
47.04%-0.49
-31.72%-0.92
6.81%-0.77
-71.20%-0.74
-8.57%-0.93
-10.87%-0.70
-46.67%-0.83
-4.14%-0.43
-56.80%-0.86
-15.57%-0.63
-123.85%-0.57
-110.36%-0.42
76.06%-0.55
-29.22%-0.54
21.70%-0.25
-1173.35%-0.20
-10317.09%-2.28
---0.42
---0.32
---0.02
---0.02
1株当たり配当金
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
通貨単位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
監査意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
